Lojuxta
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lojuxta, covering 2025-01-27 to 2025-01-27. Get the full timeline:
Most recent: EMA Authorised: Lojuxta (Lomitapide) — Chiesi Farmaceutici SpA
1 regulatory and trial event tracked for Lojuxta, covering 2025-01-27 to 2025-01-27. Get the full timeline:
Most recent: EMA Authorised: Lojuxta (Lomitapide) — Chiesi Farmaceutici SpA